Jennings v. Bayer Corporation et al

Filing 13

ORDER granting 12 Motion to Dismiss. The matter is dismissed WITH prejudice for failure to comply with Plaintiff Fact Sheet Requirements. Further, the Court DIRECTS the Clerk of the Court to enter judgment reflecting the same. Signed by Chief Judge David R. Herndon on 5/20/2013. (dsw) (Entered: 05/20/2013)

Download PDF
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ILLINOIS IN RE: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION ) ) ) ) ) 3:09-md-02100-DRH-PMF MDL No. 2100 This Document Relates to: Stacey L. Altman v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-12846-DRH-PMF Elizabeth Dinkel v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-13280-DRH-PMF Coesha Jackson v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-13111-DRH-PMF Susan D. Jennings v. Bayer Corp., et al. No. 3:11-cv-12990-DRH-PMF Daysha Kelly v. Bayer Pharma AG, et al. No. 3:11-cv-12320-DRH-PMF Patricia Lawson v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-12948-DRH-PMF Erin E. Martinez and C. John Martinez v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-13361-DRH-PMF Christine Medina v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-13222-DRH-PMF Brittany Roberts v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11575-DRH-PMF Joi Robinson v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-12950-DRH-PMF Diana J. Seymour v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-11243-DRH-PMF Sammer Yacoub v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:11-cv-13136-DRH-PMF ORDER DISMISSING WITH PREJUDICE This matter is before the Court on the defendant Bayer HealthCare Pharmaceuticals Inc.’s motion, pursuant to Case Management Order 12 (“CMO 12”), for an order dismissing the plaintiffs’ claims, in the above-captioned matters, with prejudice for failure to comply with Plaintiff Fact Sheet (“PFS”) obligations. 1 On July 2, 2012, Bayer HealthCare Pharmaceuticals Inc. moved to dismiss the above captioned matters without prejudice for failure to comply with PFS obligations. 2 The Court granted the motion on September 21, 2012. 3 In the order dismissing the above captioned actions, the Court warned the plaintiffs that, “pursuant to CMO 12 Section E, unless plaintiffs serve defendants with a COMPLETED PFS or move to vacate the dismissal without 1 The motion to dismiss filed by Bayer HealthCare Pharmaceuticals Inc. on March 28, 2013 sought dismissal of certain plaintiffs in numerous member actions. This order addresses the single plaintiff actions (including actions involving consortium claims). 2 Altman D.E. 6; McMillan D.E. 6; Dinkel D.E. 8; Hamilton D.E. 6; Jackson D.E. 6; Jennings D.E. 6; Kelly D.E. 10; Lawson D.E. 6; Martinez D.E. 8; Medina D.E. 6; Reid D.E. 6; Roberts D.E. 18; Robinson D,E. 6; Seymour D.E. 6; Shelbourne-Green D.E. 6; Yacoub D.E. 6. 3 Altman D.E. 7; McMillan D.E. 7; Dinkel D.E. 9; Hamilton D.E. 7; Jackson D.E. 7; Jennings D.E. 7; Kelly D.E. 11; Lawson D.E. 8; Martinez D.E. 9; Medina D.E. 7; Reid D.E. 7; Roberts D.E. 19; Robinson D,E. 7; Seymour D.E. 7; Shelbourne-Green D.E. 7; Yacoub D.E.7 (emphasis in original). 2 prejudice within 60 days after entry of this Order, the Order will be converted to a Dismissal With Prejudice upon defendants’ motion.” 4 On March 28, 2013, more than 60 days after the entry of the order of dismissal without prejudice, Bayer HealthCare Pharmaceuticals Inc. filed the subject motion stating that the plaintiffs are still not in compliance with their PFS obligations and asking the Court to convert the dismissals without prejudice into dismissals with prejudice pursuant to Section E of CMO 12, The Court notes that, pursuant to Section E of CMO 12, “[u]nless Plaintiff has served Defendants with a completed PFS or has moved to vacate the dismissal without prejudice within 60 days after entry of any such Order of Dismissal without Prejudice, the order will be converted to a Dismissal With Prejudice upon Defendants’ motion.” (MDL 2100 Doc. 836) (emphasis added). Accordingly, the Court could have immediately converted the above captioned dismissals to dismissals with prejudice on March 28, 2013, the day Bayer HealthCare Pharmaceuticals Inc. filed the subject motion. More than 30 days have passed since Bayer HealthCare Pharmaceuticals Inc.’s motion was filed. Thus, the plaintiffs have had ample time to cure the any PFS deficiencies and avoid a with prejudice dismissal of their claims. Having considered the motion and the relevant provisions of CMO 12 the Court ORDERS as follows: Altman D.E. 7; McMillan D.E. 7; Dinkel D.E. 9; Hamilton D.E. 7; Jackson D.E. 7; Jennings D.E. 7; Kelly D.E. 11; Lawson D.E. 8; Martinez D.E. 9; Medina D.E. 7; Reid D.E. 7; Roberts D.E. 19; Robinson D,E. 7; Seymour D.E. 7; Shelbourne-Green D.E. 7; Yacoub D.E.7. 4 3 The plaintiffs in the above-captioned actions have failed to comply with their obligations pursuant to CMO 12 and more than 60 days have passed since the entry of the order of dismissal without prejudice for failure to comply with CMO 12. Accordingly, pursuant to Section E of CMO 12, the claims of the plaintiffs in the above-captioned actions are hereby dismissed WITH prejudice. Further, the Court DIRECTS the Clerk of the Court to enter judgment reflecting the same. SO ORDERED: Digitally signed by David R. Herndon Date: 2013.05.20 11:17:29 -05'00' Chief Judge United States District Court Date: May 20, 2013 4

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?